GloBE-Reg is an international registry project. The stakeholders of this project include patients, professionals, scientific organisations and industry. 

Its mission includes:-

– Supporting the development of specific studies with a focus on effectiveness and long-term safety through routine collection of real-world data on specific classes of drugs e.g. fulfilment of post-approval regulatory requests

– Acting as a longitudinal registry study for effectiveness and long-term safety monitoring for specific drugs where a registry study does not exist

– Working in collaboration with other registries to maximize global knowledge on drug effectiveness and long-term safety

GloBE-Reg Latest News

Interest In GloBE-Reg Rises

Since the launch of the project and the registry going live in Q4, 2022, the number of visits to the website has seen a steady increase. Looking forward to the February drop-in session!

GloBE-Reg Poster at ESPE

Brad Miller presented a poster titled: The Growth Hormone Study Module For Paediatric Growth Hormone Deficiency‐ In The Global Registry For Novel Therapies In Rare Bone & Endocrine Conditions (GloBE‐Reg) on behalf of the GloBE-Reg Growth Hormone Scientific Study Group at the ESPE conference in Rome. To view the pdf of the poster click here.…

GloBE-Reg is supported by GenSci, Novo Nordisk, NHS Research Scotland and the University of Glasgow

Get in Touch

If you would like to find out more please contact info@globe-reg.net.
You can also follow us on Twitter: https://twitter.com/GloBE_Reg.